A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 and 24 Months Old
Clinical trial NCT07477132 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07477132
- Sponsor
- University Hospital, Caen
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-30
- Primary completion
- 2027-08-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.